JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2002; 40:521-528
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayward, C. S.
Right arrow Articles by Collins, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayward, C. S.
Right arrow Articles by Collins, P.

Assessment of endothelial function using peripheral waveform analysis

A clinical application

Christopher S. Hayward, MD*{dagger},*, Mustafa Kraidly, MD{dagger}, Carolyn M. Webb, PhD{dagger} and Peter Collins, MD{dagger}

* St. Vincent’s Hospital, Sydney, Australia
{dagger} National Heart and Lung Institute, Royal Brompton Hospital, London, United Kingdom



View larger version (15K):

[in a new window]
 
Figure 1 An example of the effect of Salbutamol and glyceryl trinitrate (GTN) on the radial waveform in a single individual. It can be seen that the second systolic peak, obvious at baseline, is diminished by Salbutamol and almost completely abolished following GTN. The changes in the wave-shape are quantified using the augmentation index (AIx), calculated as the ratio of the pulse pressure at the second systolic peak to that at the first systolic peak. BP = blood pressure.

 


View larger version (42K):

[in a new window]
 
Figure 2 (A, B) Salbutamol, given after saline, was associated with a significant decrease in augmentation index (AIx) compared to baseline (AIx; –11.8 ± 3.7%, p < 0.05). When given after N-{omega}-nitro-monomethyl-L-arginine (L-NMMA) there was no significant change in AIx (–2.0 ± 3.1%). The GTN was associated with a similar significant decrease in AIx after saline (–35.1 ± 3.3%) and L-NMMA (–36.5 ± 3.3%), p < 0.001 by analysis of variance (ANOVA). (C, D) There was no significant effect of either Salbutamol alone or L-NMMA on mean blood pressure (BP). The GTN was associated with a slight decrease in BP in both cases. (E, F) Salbutamol was associated with a significant increase in heart rate, which was blocked after L-NMMA infusion, p < 0.05 by ANOVA.

 


View larger version (9K):

[in a new window]
 
Figure 3 There was no relationship between the increase in heart rate (HR) seen after Salbutamol with the increase in augmentation index (AIx) seen in the same subjects (r = 0.11, p = 0.75).

 


View larger version (11K):

[in a new window]
 
Figure 4 (Top) There was good agreement between the Salbutamol-induced responses on two separate visits (r = 0.80, p < 0.01). (Bottom) As shown by the Bland-Altman analysis, there was good reproducibility and no systematic error according to magnitude of Salbutamol-induced change in augmentation index (AIx).

 


View larger version (11K):

[in a new window]
 
Figure 5 Comparison of Salbutamol and glyceryl trinitrate (GTN)-induced changes in augmentation index (AIx) in coronary artery disease patients (CAD) with control subjects. A significantly greater decrease occurred in AIx in control subjects compared to CAD patients following Salbutamol (–2.4 ± 1.9%; controls: –13.2 ± 2.3%, p < 0.002). This difference was not significant following GTN (–27.4 ± 4.2 vs. –38.9 ± 4.4%, p = 0.07).

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2002 by the American College of Cardiology Foundation.